Delivery Order SPE2DB22D3501-SPE2DB25FXM52
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,550.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dactinomycin 500 microgram vials, with an ultimate completion date of September 18, 2025. This non-set-aside delivery order represents a competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,028,451 units of the pharmaceutical product dactinomycin 500 mcg vials. The $3,570.00 contract has a performance period ending on March 21, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor for this delivery order. The award is not associated with a set-aside...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 mcg vials of the drug dactinomycin. The contract has a ceiling value of $10,200.00 and a period of performance through November 4, 2024. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen, a for-profit organization, is providing these pharmaceutical products to support...
- The Defense Logistics Agency awarded a $5,492.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Dactinomycin 500 mcg vials. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency requirements. No major subcontractors or set aside designations were identified. The delivery order was awarded under an existing DLA pharmaceuticals contract vehicle and will provide needed chemotherapy...
- This federal contract award is for the delivery of DACTINOMYCIN 500 MCG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor, Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, will provide these pharmaceutical products under a firm fixed price delivery order. The potential value of this award is $4,057.18 with a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.90 to AmerisourceBergen Drug Corp for Doxorubicin 200 mg/100 mL vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single-line pharmaceutical procurement executed under the company's larger contract vehicle with DLA. The product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxorubicin 200 mg/100 mL vials totaling $1,928.51 with a firm fixed price arrangement. The contract, which is non-set-aside and competitively awarded, was finalized on July 22, 2025, with an ultimate completion date of July 23, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,126.05 to AmerisourceBergen Drug Corp for Doxorubicin Liposome 50mg/25ml on July 31, 2025, with completion scheduled for August 1, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's established relationship with the federal government as a critical pharmaceutical distributor. The order is being fulfilled from the vendor's location in...
- This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...